Clinically reviewed by Dr. Ponlawat Pitsuwan, Physician, Doctor Samui.
Last reviewed: October 2026
Rybelsus is an oral tablet containing semaglutide, a GLP-1 receptor agonist taken once daily. It is registered for type 2 diabetes and prescribed off-label for weight loss. Injectable semaglutide (Ozempic, Wegovy) produces greater average weight loss than the oral tablet at currently available doses, but Rybelsus is a real option for people who cannot or will not use injections. Both require a doctor’s assessment before starting.
You have been on Samui for a few months, managing your weight and blood sugar between scooter rides and beach days, and semaglutide came up in a conversation with your doctor before you left home. Now you are trying to work out whether the tablet version is worth it or whether you need the injection. That is a reasonable question, and the answer depends on what you are actually trying to achieve.
Rybelsus oral semaglutide works. It just works differently from the weekly injection, and the gap in results matters. If you are deciding between the two, or wondering whether you can get either one here on Koh Samui, here is what you need to know.

How Rybelsus Is Absorbed, and Why the Fasting Rule Is Not Optional
Semaglutide taken by mouth would normally be destroyed by stomach acid before it reaches your bloodstream. Rybelsus gets around this using a compound called SNAC (sodium N-[8-(2-hydroxybenzoyl) amino caprylate). SNAC raises the local pH around the dissolving tablet, protecting the semaglutide long enough to pass through the stomach lining and into your blood.
This only works under very specific conditions. Food and large amounts of liquid disrupt the effect. The prescribing label requires you to take Rybelsus on a completely empty stomach with no more than 120 ml of water, then wait at least 30 minutes before eating, drinking anything else, or taking other medications. Miss that window consistently and the tablet is not doing much.
Rybelsus Dosage, Starting Low and Stepping Up
Rybelsus comes in 3 mg, 7 mg, and 14 mg tablets. You start at 3 mg for the first month. That dose is not therapeutic; it is there to let your digestive system adjust and reduce early nausea. After a month you move to 7 mg, which is the first clinically active dose. If you tolerate it well and need more effect, 14 mg is the maximum.
This titration schedule is fixed on the prescribing label. Skipping steps to get faster results does not work the way patients hope. It significantly increases the chance of nausea and vomiting severe enough to make you stop altogether.

Weight Loss Results, What the Trial Data Actually Shows
The honest comparison between oral and injectable semaglutide is not straightforward, because the key trials used different doses, durations, and patient populations.
| Rybelsus 14 mg (PIONEER 1) | Semaglutide injection 2.4 mg (STEP 1) | |
|---|---|---|
| Population | Adults with type 2 diabetes | Adults with obesity, no diabetes |
| Duration | 26 weeks | 68 weeks |
| Average weight change | Approx. 4.1 kg loss | Approx. 14.9% body weight loss |
| Route | Once-daily oral tablet | Once-weekly subcutaneous injection |
| Primary endpoint | HbA1c reduction | Body weight reduction |
The injection reaches higher levels in the blood because it bypasses the gut entirely. Higher exposure means more appetite suppression and more weight loss on average. That gap is real. For most people whose primary goal is significant weight reduction, the injectable form has stronger evidence.
For blood sugar control in type 2 diabetes, the PIONEER trials showed that oral semaglutide at 14 mg produced meaningful reductions in HbA1c, the three-month average blood glucose level. It is an effective diabetes medication. The weight loss benefit at the oral dose currently available is secondary.
Who Does Better on Tablets, and When Injections Win
Some people genuinely cannot use injections: needle phobia, travel schedules that make weekly cold-chain storage impractical, or a strong preference for a daily tablet routine. For those patients, Rybelsus is a legitimate option. Some weight loss, meaningful blood sugar improvement, and no needles.
Injections win when the goal is significant weight reduction. If you are carrying a lot of extra weight, managing obesity-related conditions, or want the cardiovascular protection data that injectable semaglutide has shown in trials like SUSTAIN-6 and SELECT, the injection is the stronger clinical choice. Oral semaglutide now has cardiovascular outcome data: the SOUL trial, presented in March 2025, showed that oral semaglutide 14 mg reduced major adverse cardiovascular events by 14% versus placebo in adults with type 2 diabetes and established cardiovascular disease or chronic kidney disease. Whether this evidence is equivalent to that for the injectable forms in all patient groups is still a clinical judgment.
Which form suits you is a clinical conversation, not a comparison-website decision. At Doctor Samui we look at your blood glucose, BMI, and overall health picture before recommending either option.
Side Effects, Oral vs Injectable Semaglutide
The side effect profile is similar for both forms because the active molecule is the same. Nausea is the most common complaint, especially in the first few weeks. Some people get loose stools, stomach discomfort, or reduced appetite to a degree that makes eating feel difficult.
The nausea tends to be front-loaded: worse when starting or stepping up the dose, then settling. Eating smaller meals and avoiding fatty or rich food helps. If vomiting is persistent or you cannot keep fluids down, that warrants a clinical review, not just pushing through. People on the oral tablet sometimes find the nausea more variable day to day, possibly from inconsistent absorption linked to the fasting window.
Taking Rybelsus in Samui’s Heat, Storage and Travel Practicalities
This is where island life creates a specific problem. Rybelsus tablets should be stored below 30°C, away from moisture and direct sunlight. Samui’s ambient temperature sits at or above that threshold for much of the year.
Do not leave your tablets in a beach bag, a hire car, a non-air-conditioned bungalow, or on a windowsill. Keep them in their original blister packaging in an air-conditioned room. If you are doing a full-day boat trip out from Maenam or a long loop around the ring road, your medication stays at the accommodation, not in your bag.
The fasting window also needs planning around island mornings. Early starts on Samui often mean coffee and a beach breakfast straight away. You need to take your tablet first, wait 30 minutes with nothing else, then eat. Set an alarm, take the tablet, then go back to sleep or wait before breakfast. It is manageable, but it requires discipline every single day.
Getting Rybelsus on Koh Samui, Prescription and Monitoring
Rybelsus is available in Thailand and requires a prescription from a licensed physician. Starting semaglutide without checking your baseline blood glucose, kidney function, and contraindications is not safe, particularly if you are managing diabetes.
At our Chaweng clinic, we offer GLP-1 consultations for both tourists and long-stay expats. We assess whether Rybelsus or the injectable form is more appropriate, prescribe at the right starting dose, and arrange a follow-up blood sugar check at around 30 days. If you are already on Rybelsus from your home country and need a prescription continuation on Samui, we can help with that too. Our mobile doctor services across Koh Samui mean a consultation does not always require coming into the clinic.
People who should not take Rybelsus include those with a personal or family history of medullary thyroid carcinoma, those with multiple endocrine neoplasia syndrome type 2 (a condition where tumours grow in glands throughout the body), and those who are pregnant or breastfeeding. A history of pancreatitis requires careful clinical review before starting any GLP-1 therapy. We go through all of this as part of every semaglutide consultation.
For a full overview of how we approach GLP-1 prescribing on Koh Samui, see our dedicated page on semaglutide tablets vs injections. If you are also due a general health review, our health check-up service in Koh Samui covers baseline bloods at the same visit.
Thinking about starting Rybelsus or switching from an injection? Doctor Samui’s clinic in Chaweng offers GLP-1 consultations for tourists and long-stay expats. We assess your suitability, prescribe at the correct dose, and arrange follow-up blood sugar monitoring. Walk in or contact us to arrange an appointment.
FAQ
Dr. Ponlawat Pitsuwan
Physician, Doctor Samui
a walk-in clinic based in Chaweng, Koh Samui, with 24-hour hotel and villa visits across the island. He sees tourists, families, and long-stay expats for weight management, diabetes care, and GLP-1 therapy including semaglutide consultations, prescribing, and follow-up monitoring. His focus is straightforward, evidence-based care delivered in plain language.
References
- Aroda VR, et al. PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes. Diabetes Care. 2019.
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. 2021.
- Marso SP, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). New England Journal of Medicine. 2016.
- Novo Nordisk. Rybelsus (semaglutide) Prescribing Information. U.S. Food and Drug Administration. 2019.
- Novo Nordisk. SOUL cardiovascular outcomes trial: oral semaglutide 14 mg demonstrates superior reduction in cardiovascular events. Press release, March 2025.
The information in this article is for educational purposes only and does not constitute medical advice. It should not be used to self-diagnose or replace a consultation with a qualified physician. If you have concerns about your health, contact a licensed medical professional. For appointments at Doctor Samui, visit doctorsamui.com.


